Griffin's Citadel Shows New 6.5% Stake in Inotek Pharmaceuticals (ITEK)

August 29, 2016 10:02 AM EDT
Get Alerts ITEK Hot Sheet
Trade ITEK Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

In a 13G filing on Inotek Pharmaceuticals (NASDAQ: ITEK), Ken Griffin's hedge fund Citadel disclosed a 6.5%, or 1,875,432 share, stake in the company.

For more notable holders of Inotek Pharmaceuticals stock click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

13Gs, Hedge Funds

Related Entities

Citadel, Ken Griffin, 13G

Add Your Comment